{
    "name": "lansoprazole/amoxicillin/clarithromycin",
    "comment": "Rx",
    "other_names": [
        "Prevpac"
    ],
    "classes": [
        "H pylori Agents",
        "PUD Combos"
    ],
    "source": "https://reference.medscape.com/drug/prevpac-lansoprazole-amoxicillin-clarithromycin-999477",
    "pregnancy": {
        "common": [
            "Caution should be exercised when clarithromycin is administered to nursing women; the development and health benefits of human milk feeding should be considered along with the mother’s clinical need for clarithromycin and any potential adverse effects on human milk- fed child from the drug or from underlying maternal condition"
        ],
        "specific": [
            {
                "type": "Clarithromycin",
                "description": [
                    "No adequate and well-controlled studies in pregnant women; do not use clarithromycin in pregnant women except in circumstances in which no alternative therapy is appropriate",
                    "If pregnancy occurs while taking clarithromycin, inform patient of paotential hazard to fetus; drug has demonstrated adverse effects of prengnacy outcome and/or embryofetal development in monkeys, rats, mice, and rabbits at doses that produced plasma levels 2 to 17 times serum levels achieved in humans treated at maximum recommended human doses"
                ]
            },
            {
                "type": "Lansoprazole",
                "description": [
                    "Available data from published observational studies overall do not indicate an association of adverse pregnancy outcomes with lansoprazole treatment; estimated background risk of major birth defects and miscarriage for the indicated populations are unknown",
                    "Available data from published observational studies failed to demonstrate an association of adverse pregnancy-related outcomes and lansoprazole use; methodological limitations of these observational studies cannot definitely establish or exclude any drug-associated risk during pregnancy",
                    "No adverse effects on embryo-fetal development occurred in studies performed in pregnant rats at oral lansoprazole doses up to 150 mg/kg/day (40 times the recommended human dose [30 mg/day] based on body surface area) administered during organogenesis and pregnant rabbits at oral lansoprazole doses up to 0 mg/kg/day (16 times the recommended human dose based on body surface area) administered during organogenesis"
                ]
            },
            {
                "type": "Amoxicillin",
                "description": [
                    "Adverse events not observed in animal reproduction studies; maternal use has not resulted in increased risk of adverse fetal effects; however, possible association with cleft lip with cleft palate observed in some studies; more data needed"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Caution should be exercised when clarithromycin is administered to nursing women; the development and health benefits of human milk feeding should be considered along with the mother’s clinical need for clarithromycin and any potential adverse effects on human milk- fed child from the drug or from underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [],
            "specific": []
        },
        "cautions": {
            "common": [
                "Consider possibility of superinfections with fungal or bacterial pathogens during therapy; if superinfections occur, discontinue therapy and institute appropriate therapy; prescribing therapy either in absence of proven or strongly suspected bacterial infection is unlikely to provide benefit to patient and increases risk of development of drug-resistant bacteria",
                "Serious adverse reactions reported with clarithromycin concomitantly with CYP3A4 substrates; these include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; hypoglycemia with disopyramide, and hypotension and acute kidney injury with calcium channel blockers metabolized by CYP3A4 (eg, verapamil, amlodipine, diltiazem, nifedipine); most reports of acute kidney injury with calcium channel blockers metabolized by CYP3A4 involved elderly patients 65 years of age or older; clarithromycin should be used with caution when administered concurrently with medications that induce cytochrome CYP3A4 enzyme"
            ],
            "specific": [
                {
                    "type": "Lansoprazole",
                    "description": [
                        "Liver disease may require dosage reduction",
                        "Published observational studies suggest that proton pump inhibitor (PPI) therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine; particularly with prolonged (>1 yr), high-dose therapy",
                        "Cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE) reported with PPIs; avoid using for longer than medically indicated; discontinue if signs or symptoms consistent with CLE or SLE are observed and refer patient to specialist",
                        "Hypomagnesemia may occur with prolonged use (ie, >1 year); adverse effects may result and include tetany, arrhythmias, or seizures; in 25% of cases reviewed, magnesium supplementation alone did not improve low serum magnesium levels and the PPI had to be discontinued",
                        "PPIs possibly associated with increased incidence of Clostridium difficile-associated diarrhea (CDAD); consider diagnosis of CDAD for patients taking PPIs with diarrhea that does not improve",
                        "Symptomatic response to therapy with lansoprazole does not preclude the presence of gastric malignancy; consider additional follow-up and diagnostic testing in adult patients who have a suboptimal response or an early symptomatic relapse after completing treatment with a PPI; in older patients, also consider endoscopy",
                        "PPIs may elevate and prolong methotrexate or its metabolite serum levels, possibly leading to toxicity",
                        "PPI therapy is associated with increased risk of fundic gland polyp; risk increases with long-term use >1 year; patient may be asymptomatic; problem usually identified incidentally on endoscopy; use shortest duration of therapy appropriate to condition being treated",
                        "Acute interstitial nephritis (AIN) observed in patients taking proton pump inhibitors (PPIs) including lansoprazole; acute interstitial nephritis may occur at any point during PPI therapy and is generally attributed to an idiopathic hypersensitivity reaction; discontinue lansoprazole if AIN develops"
                    ]
                },
                {
                    "type": "Amoxicillin",
                    "description": [
                        "Allergy to cephalosporins, carbapenems",
                        "Endocarditis prophylaxis: use only for high risk pts, per recent AHA Guidelines",
                        "High doses may cause false urine glucose test by some methods"
                    ]
                },
                {
                    "type": "Clarithromycin",
                    "description": [
                        "Caution in severe renal or hepatic impairment; in presence of severe renal impairment with or without coexisting hepatic impairment, decreased dosage or prolonged dosing intervals of clarithromycin may be appropriate",
                        "Do not refrigerate oral solution",
                        "Endocarditis prophylaxis: use only for high risk patients, per recent AHA Guidelines",
                        "Drug has been associated with prolongation of QT interval and infrequent cases of arrhythmia; cases of ",
                        "torsades de pointes ",
                        "spontaneously reported during postmarketing surveillance; fatalities reported; avoid therapy in patients with ongoing proarrhythmic conditions such as uncorrected hypokalemia or hypomagnesemia, clinically significant bradycardia and in patients receiving Class IA (quinidine, procainamide) or Class III (dofetilide, amiodarone, sotalol) antiarrhythmic agents; elderly patients may be more susceptible to drug-associated effects on the QT interval",
                        "Concomitant use of clarithromycin and oral hypoglycemic agents and/or insulin can result in significant hypoglycemia",
                        "There is a risk of serious hemorrhage and significant elevations in INR and prothrombin time when clarithromycin is co-administered with warfarin; monitor INR and prothrombin times",
                        "Hepatic dysfunction, including increased liver enzymes, and hepatocellular and/or cholestatic hepatitis, with or without jaundice, reported with drug; hepatic dysfunction may be severe and usually reversible; in some instances, hepatic failure with fatal outcome reported and generally associated with serious underlying diseases and/or concomitant medications; symptoms of hepatitis can include anorexia, jaundice, dark urine, pruritus, or tender abdomen; discontinue clarithromycin immediately if signs and symptoms of hepatitis occur",
                        "Hypersensitivity reactions",
                        "Individuals with a history of penicillin hypersensitivity who have experienced severe reactions when treated with cephalosporins reported",
                        "Before initiating therapy perform careful inquiry regarding previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens",
                        "In the event of severe acute hypersensitivity reactions, such as anaphylaxis, Stevens-Johnson Syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS), and Henoch-Schonlein purpura discontinue therapy immediately and urgently initiate appropriate treatment "
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "GI effects",
            "percent": "13"
        },
        {
            "name": "general",
            "percent": "6"
        },
        {
            "name": "Headache",
            "percent": "3"
        },
        {
            "name": "Rash",
            "percent": "2"
        },
        {
            "name": "children",
            "percent": "3"
        },
        {
            "name": "Abdominal pain",
            "percent": "3-7"
        },
        {
            "name": "adults",
            "percent": "3-6"
        },
        {
            "name": "children",
            "percent": "2"
        },
        {
            "name": "Abnormal taste",
            "percent": "2"
        },
        {
            "name": "adults",
            "percent": "3-6"
        },
        {
            "name": "Diarrhea",
            "percent": "1"
        },
        {
            "name": "Dyspepsia",
            "percent": "6"
        },
        {
            "name": "Heartburn",
            "percent": "4"
        },
        {
            "name": "adults",
            "percent": "1"
        },
        {
            "name": "GI intolerance",
            "percent": "3"
        },
        {
            "name": "oral",
            "percent": "2.5-4.7"
        },
        {
            "name": "dose related",
            "percent": "1.8"
        },
        {
            "name": "Nausea",
            "percent": "8"
        },
        {
            "name": "adults",
            "percent": "3.7"
        },
        {
            "name": "Vomiting",
            "percent": null
        },
        {
            "name": "adults",
            "percent": null
        },
        {
            "name": "children",
            "percent": null
        },
        {
            "name": "Decreased WBC",
            "percent": null
        },
        {
            "name": "elevated BUN",
            "percent": null
        },
        {
            "name": "elevated PT",
            "percent": null
        },
        {
            "name": "Fatigue",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "QT prolongation",
            "percent": null
        },
        {
            "name": "Anxiety",
            "percent": null
        },
        {
            "name": "dizziness",
            "percent": null
        },
        {
            "name": "hallucinations",
            "percent": null
        },
        {
            "name": "manic behavior",
            "percent": null
        },
        {
            "name": "neuromuscular blockade",
            "percent": null
        },
        {
            "name": "psychosis",
            "percent": null
        },
        {
            "name": "seizures",
            "percent": null
        },
        {
            "name": "Anorexia",
            "percent": null
        },
        {
            "name": "glossitis",
            "percent": null
        },
        {
            "name": "pancreatitis",
            "percent": null
        },
        {
            "name": "AST increased",
            "percent": null
        },
        {
            "name": "bilirubin increased",
            "percent": null
        },
        {
            "name": "elevated LFTs",
            "percent": null
        },
        {
            "name": "hepatic dysfunction",
            "percent": null
        },
        {
            "name": "hepatitis",
            "percent": null
        },
        {
            "name": "increased alkaline phosphate",
            "percent": null
        },
        {
            "name": "jaundice",
            "percent": null
        },
        {
            "name": "Hypoglycemia",
            "percent": null
        },
        {
            "name": "leukopenia",
            "percent": null
        },
        {
            "name": "neutropenia",
            "percent": null
        },
        {
            "name": "thrombocytopenia",
            "percent": null
        },
        {
            "name": "Increased serum creatinine",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Anaphylaxis",
            "percent": null
        },
        {
            "name": "C Diff colitis",
            "percent": null
        },
        {
            "name": "Stevens",
            "percent": null
        },
        {
            "name": "Johnson syndrome",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "nausea",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "Anemia",
            "percent": null
        },
        {
            "name": "AST",
            "percent": null
        },
        {
            "name": "ALT elevation",
            "percent": null
        },
        {
            "name": "Acute exanthematous pustulosis",
            "percent": null
        },
        {
            "name": "Exfoliative dermatitis",
            "percent": null
        },
        {
            "name": "Seizure",
            "percent": null
        },
        {
            "name": "Insomnia",
            "percent": null
        },
        {
            "name": "Hemorrhagic colitis",
            "percent": null
        },
        {
            "name": "Toxic epidermal necrolysis",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Stevens",
            "percent": null
        },
        {
            "name": "Johnson syndrome",
            "percent": null
        },
        {
            "name": "Anaphylaxis",
            "percent": null
        },
        {
            "name": "Candidiasis",
            "percent": null
        },
        {
            "name": "mucocutaneous",
            "percent": null
        },
        {
            "name": "pseudomembranous colitis",
            "percent": null
        },
        {
            "name": "serum sickness",
            "percent": null
        },
        {
            "name": "Torsade de pointes",
            "percent": null
        },
        {
            "name": "rare",
            "percent": null
        },
        {
            "name": "Allergic reactions",
            "percent": null
        },
        {
            "name": "urticaria",
            "percent": null
        },
        {
            "name": "skin eruptions",
            "percent": null
        },
        {
            "name": "leukocytoclastic vasculitis",
            "percent": null
        },
        {
            "name": "toxic epidermal necrolysis",
            "percent": null
        },
        {
            "name": "pruritus",
            "percent": null
        },
        {
            "name": "rash",
            "percent": null
        },
        {
            "name": "Transient CNS effects",
            "percent": null
        },
        {
            "name": "psychosis",
            "percent": null
        },
        {
            "name": "anxiety",
            "percent": null
        },
        {
            "name": "behavioral changes",
            "percent": null
        },
        {
            "name": "confusional states",
            "percent": null
        },
        {
            "name": "depersonalization",
            "percent": null
        },
        {
            "name": "disorientation",
            "percent": null
        },
        {
            "name": "hallucinations",
            "percent": null
        },
        {
            "name": "insomnia",
            "percent": null
        },
        {
            "name": "nightmares",
            "percent": null
        },
        {
            "name": "tinnitus",
            "percent": null
        },
        {
            "name": "tremor",
            "percent": null
        },
        {
            "name": "and vertigo",
            "percent": null
        },
        {
            "name": "Hepatic failure",
            "percent": null
        },
        {
            "name": "Stomatitis",
            "percent": null
        },
        {
            "name": "Acute renal failure",
            "percent": null
        },
        {
            "name": "Reversible hearing loss",
            "percent": null
        },
        {
            "name": "hypoacusis",
            "percent": null
        },
        {
            "name": "Fundic gland polyps",
            "percent": null
        }
    ]
}